Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer

Journal of Urology

Volumn 156, Issue 1, 1996, Pages 56-60

  Rintala, Erkki ^a   Jauhiainen, Kari ^a   Kaasinen, Eero ^a   Nurmi, Martti ^a   Alfthan, Olof ^a   Hansson, E ^a   Juusela, H ^a   Kanerva, K ^a   Korhonen, H ^a   Permi, J ^a   Petays P ^a   Puolakka, V M ^a   Rajala, P ^a   Ruutu, M ^a   Tainio, H ^a   Talja, M ^a   Tuhkanen, K ^a   Viitanen, J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

BCG vaccine; bladder neoplasms; immunotherapy; mitomycin C

Indexed keywords

BCG VACCINE; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT CANCER;

EID: 8944234345     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65936-6     Document Type: Article

References (21)

1. Sarosdy, M. F. and Lamm, D. L.: Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. J. Urol., 142: 719, 1989.
2. Tolley, D. A., Hargreave, T. B., Smith, P. H., Williams, J. L., Grigor, K. M., Parmar, M. K. B., Freedman, L. S. and Uscinska, B. M.: Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Brit. Med. J., 296: 1759, 1988.
3. Martinez-Piñeiro, J. A., León, J. J., Martinez-Piñeiro, L., Jr., Fiter, L., Mosteiro, J. A., Navarro, J., Garcia Matres, M. J. and Carcamo, P.: Bacillus Calmette-Guérin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. J. Urol., 143: 502, 1990.
4. Lamm, D. L., Blumenstein, B. A., Crawford, E. D., Montie, J. E., Scardino, P., Grossman, H. B., Stanisic, T. H., Smith, J. A., Jr., Sullivan, J., Sarosdy, M. F., Crissman, J. D. and Coltman, C. A.: A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitionalcell carcinoma of the bladder. New Engl. J. Med., 325: 1205, 1991.
5. Rintala, E., Jauhiainen, K., Alfthan, O., Hansson, E., Juusela, H., Kanerva, K., Korhonen, H., Permi, J., Sotarauta, M., Vaalasti, T., Viitanen, J. and Usenius, R.: Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guérin) in superficial bladder cancer. Eur. Urol., 20: 19, 1991.
6. Rintala, E., Jauhiainen, K., Rajala, P., Ruutu, M., Kaasinen, E., Alfthan, O. and the Finnbladder Group: Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. J. Urol., 154: 2050, 1995.
7. Eksborg, S., Nilsson, S. O. and Edsmyr, F.: Intravesical instillation of Adriamycin. A model for standardization of the chemotherapy. Eur. Urol., 6: 218, 1980.
8. Jauhiainen, K., Kangas, L., Käpylä, H. and Alfthan, O.: Intravesical cytostatics: pH-dependence of antitumour activity. Urol. Res., 13: 19, 1985.
9. Soloway, M. S.: Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients. J. Urol., 134: 1107, 1985.
10. Jauhiainen, K. and Alfthan, O.: Instillation of mitomycin C and doxorubicin in the prevention of recurrent superficial (Ta-T1) bladder cancer. Brit. J. Urol., 60: 54, 1987.
11. Huland, H., Klöppel, G., Feddersen, I., Otto, U., Brachmann, W., Hubmann, H., Kaufmann, J., Knipper, W., Lantzius-Beninga, F. and Huland, E.: Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients. J. Urol., 144: 68, 1990.
12. Herr, H. W., Laudone, V. P., Badalament, R. A., Oettgen, H. F., Sogani, P. C., Freedman, B. D., Melamed, M. R. and Whitmore, W. F., Jr.: Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. J. Clin. Oncol., 6: 1450, 1988.
13. Rintala, E., Hannisdahl, E., Fosså, S. D., Hellsten, S. and Sander, S.: Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I. Scand. J. Urol. Nephrol., 27: 355, 1993.
14. Rajala, P., Kaasinen, E., Rintala, E., Jauhiainen, K., Nurmi, M., Alfthan, O. and Lähde, M.: Cytostatic effect of different strains of bacillus Calmette-Guérin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alfa. Urol. Res., 20: 215, 1992.
15. Vegt, P. D. J., Witjes, J. A., Witjes, W. P. J., Doesburg, W. H., Debruyne, F. M. J. and van der Meijden, A. P. M.: A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder. J. Urol., part 2, 153: 929, 1995.
16. Oosterlinck, W., Kurth, K. H., Schröder, F., Bultinck, J., Hammond, B., Sylvester, R. and members of the European Organization for Research and Treatment of Cancer Genitourinary Group: A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J. Urol., 149: 749, 1993.
17. Lamm, D. L., van der Meijden, A. P. M., Morales, A., Brosman, S. A., Catalona, W. J., Herr, H. W., Soloway, M. S., Steg, A. and Debruyne, F. M. J.: Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol., 147: 596, 1992.
18. Lamm, D. L.: Bacillus Calmette-Guerin immunotherapy for bladder cancer. J. Urol., 134: 40, 1985.
19. Badalament, R. A., Herr, H. W., Wong, G. Y., Gnecco, C., Pinsky, C. M., Whitmore, W. F., Jr., Fair, W. R. and Oettgen, H. F.: A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. J. Clin. Oncol., 5: 441, 1987.
20. Torrence, R. J., Kavoussi, L. R., Catalona, W. J. and Ratliff, T. L.: Prognostic factors in patients treated with intravesical bacillus Calmette-Guerin for superficial bladder cancer. J. Urol., 139: 941, 1988.
21. Jakse, G.: BCG for carcinoma in situ. Eur. Urol., suppl 2, 21: 30, 1992.